PATHOGENETIC TREATMENT OF ARTERIAL HYPERTENSION: THE PLACE OF CALCIUM ANTAGONISTS

The paper describes the key aspects of arterial hypertension pathogenesis and the relevant therapeutic strategies. The authors discuss the role of increased peripheral vascular resistance and hypervolemia as factors which can be targeted by calcium channel blockers. The new evidence on this medicati...

Full description

Saved in:
Bibliographic Details
Main Authors: E. O. Taratukhin, N. N. Teplova
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2013-04-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/182
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849408471641882624
author E. O. Taratukhin
N. N. Teplova
author_facet E. O. Taratukhin
N. N. Teplova
author_sort E. O. Taratukhin
collection DOAJ
description The paper describes the key aspects of arterial hypertension pathogenesis and the relevant therapeutic strategies. The authors discuss the role of increased peripheral vascular resistance and hypervolemia as factors which can be targeted by calcium channel blockers. The new evidence on this medication class, including the third-generation calcium antagonists, is presented.
format Article
id doaj-art-5e860079eb0f485b8f129768b6c2ff39
institution Kabale University
issn 1728-8800
2619-0125
language Russian
publishDate 2013-04-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-5e860079eb0f485b8f129768b6c2ff392025-08-20T03:35:47Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252013-04-01122858810.15829/1728-8800-2013-2-85-88182PATHOGENETIC TREATMENT OF ARTERIAL HYPERTENSION: THE PLACE OF CALCIUM ANTAGONISTSE. O. Taratukhin0N. N. Teplova1N. I. Pirogov National Medical Research UniversityN. I. Pirogov National Medical Research UniversityThe paper describes the key aspects of arterial hypertension pathogenesis and the relevant therapeutic strategies. The authors discuss the role of increased peripheral vascular resistance and hypervolemia as factors which can be targeted by calcium channel blockers. The new evidence on this medication class, including the third-generation calcium antagonists, is presented.https://cardiovascular.elpub.ru/jour/article/view/182vasospasmhypervolemiahypernatremiacardiac output
spellingShingle E. O. Taratukhin
N. N. Teplova
PATHOGENETIC TREATMENT OF ARTERIAL HYPERTENSION: THE PLACE OF CALCIUM ANTAGONISTS
Кардиоваскулярная терапия и профилактика
vasospasm
hypervolemia
hypernatremia
cardiac output
title PATHOGENETIC TREATMENT OF ARTERIAL HYPERTENSION: THE PLACE OF CALCIUM ANTAGONISTS
title_full PATHOGENETIC TREATMENT OF ARTERIAL HYPERTENSION: THE PLACE OF CALCIUM ANTAGONISTS
title_fullStr PATHOGENETIC TREATMENT OF ARTERIAL HYPERTENSION: THE PLACE OF CALCIUM ANTAGONISTS
title_full_unstemmed PATHOGENETIC TREATMENT OF ARTERIAL HYPERTENSION: THE PLACE OF CALCIUM ANTAGONISTS
title_short PATHOGENETIC TREATMENT OF ARTERIAL HYPERTENSION: THE PLACE OF CALCIUM ANTAGONISTS
title_sort pathogenetic treatment of arterial hypertension the place of calcium antagonists
topic vasospasm
hypervolemia
hypernatremia
cardiac output
url https://cardiovascular.elpub.ru/jour/article/view/182
work_keys_str_mv AT eotaratukhin pathogenetictreatmentofarterialhypertensiontheplaceofcalciumantagonists
AT nnteplova pathogenetictreatmentofarterialhypertensiontheplaceofcalciumantagonists